drugset / Trial / NCT05170672

Expanded Access for Abatacept

NCT05170672

Expanded access No longer available Bristol-Myers Squibb

Summary

This is an expanded access designed to provide access to abatacept for eligible participants.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Abatacept Other / unclassified

Indications

No indication recorded.